ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,383Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 973

$758K Total Retail Price of All Prescriptions

Rank: 33 out of 973

704 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 748 627 1 7
HYDROCODONE-ACETAMINOPHEN 710 424 S3 2 4
HYDROCHLOROTHIAZIDE 707 532 3 11
SIMVASTATIN 511 366 4 1
OMEPRAZOLE 487 376 5 5
LEVOTHYROXINE SODIUM 410 284 6 2
CITALOPRAM HBR 403 331 7 14
METFORMIN HCL 400 299 8 8
LISINOPRIL 380 221 9 3
GABAPENTIN 317 131 10 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 309 226 11 25
FUROSEMIDE 273 230 12 6
TRIAMTERENE-HCTZ 241 188 13 51
RANITIDINE HCL 227 123 14 45
LOSARTAN-HYDROCHLOROTHIAZIDE 204 187 15 46
ATENOLOL 189 147 16 16
MORPHINE SULFATE ER 168 21 S2 17 74
MELOXICAM 165 76 18 23
METOPROLOL TARTRATE 159 118 19 13
SPIRIVA 153 102 20 73
PROAIR HFA 152 93 21 54
LOVASTATIN 151 131 22 38
METOPROLOL SUCCINATE 143 132 23 17
POTASSIUM CHLORIDE 143 102 23 9
CARVEDILOL 140 97 25 27
GLIMEPIRIDE 140 125 25 41
OXYCODONE HCL-ACETAMINOPHEN 128 26 S2 27 104
WARFARIN SODIUM 127 111 28 10
ALLOPURINOL 126 113 29 29
NAMENDA 124 124 30 31
CYCLOBENZAPRINE HCL 121 16 R 31 42
LOSARTAN POTASSIUM 114 105 32 19
LANTUS 108 65 33 39
OXYCODONE-ACETAMINOPHEN 101 46 S2 34 89
POLYETHYLENE GLYCOL 3350 98 76 35 36
DONEPEZIL HCL 98 93 35 26
SERTRALINE HCL 97 66 37 21
PAROXETINE HCL 96 59 38 66
LANTUS SOLOSTAR 88 42 39 99
KLOR-CON M20 87 85 40 64
DIGOXIN 86 70 41 32
ZOLPIDEM TARTRATE 82 47 42 20
TRAMADOL HCL 81 53 43 18
GLYBURIDE 80 68 R 44 59
NEXIUM 80 27 44 30
TAMSULOSIN HCL 79 68 46 28
DOXYCYCLINE HYCLATE 77 43 47 96
DOXAZOSIN MESYLATE 76 68 48 87
BISOPROLOL-HYDROCHLOROTHIAZIDE 74 67 49 142
TRAZODONE HCL 73 39 50 48
CELEBREX 71 42 51 91
CLONIDINE HCL 71 51 51 67
ATORVASTATIN CALCIUM 70 45 53 15
AMOXICILLIN 70 42 53 101
CRESTOR 70 43 53 34
FLUOXETINE HCL 69 49 56 56
INSULIN SYRINGE 68 39 57 153
FELODIPINE ER 62 61 58 210
PANTOPRAZOLE SODIUM 61 49 59 37
CIPROFLOXACIN HCL 59 48 60 57
SPIRONOLACTONE 58 33 61 49
IBUPROFEN 53 19 62 102
SYMBICORT 53 35 62 163
LYRICA 52 28 64 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.